Canaccord Genuity Maintains Buy on Insulet, Raises Price Target to $428

Insulet Corporation -2.73% Post

Insulet Corporation

PODD

296.19

296.19

-2.73%

0.00% Post
Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ: PODD) with a Buy and raises the price target from $399 to $428.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via